ResearchKit

By  Dave Muoio 03:30 pm June 7, 2018
Deep breaths. Henry Schein Medical announced today the launch of its EasyOne Air Spirometer, a device designed to measure lung function and improve diagnosis of COPD. Connected via Bluetooth, the spirometer includes a touch screen interface, EHR connectivity, and proprietary technology to improve device calibration and accuracy. "We are excited to work with ndd [the device’s designer] to provide...
By  Jonah Comstock 04:20 pm March 12, 2018
Duke University has launched a new Apple ResearchKit study, the MS Mosaic Study, aimed at using big data and patient insights to improve medical understanding of multiple sclerosis. Dr. Lee Hartsell, assistant professor of neurology at Duke University Medical Center, spoke about the new study -- and some of the challenges involved in launching it -- at the Digital and Personal Connect...
By  Jonah Comstock 09:02 am November 30, 2017
The Apple Heart Study, an Apple Watch-based ResearchKit study using the heart rate sensor to look at potential arrhythmias, is launching today, the Cupertino tech giant told MobiHealthNews. Apple Chief Operations Officer Jeff Williams announced the study, which is being conducted in collaboration with Stanford University and with assistance from American Well, at Apple’s iOS 8 launch event in...
By  Tom Sullivan 03:16 pm October 30, 2017
The Scripps Research Institute on Wednesday announced a new smartphone app that can calculate a user’s risk of heart disease. Hospitals will want to keep an eye on the research study that Scripps conducts about the effectiveness of giving patients predictions concerning adverse health events and what impact that could have on influencing healthy behaviors and lifestyle changes. Scripps MyGeneRank...
By  Dave Muoio 02:27 pm October 5, 2017
Purdue Pharma and Geisinger announced today that the first patient has been enrolled in the companies’ upcoming trial of medical wearables as an alternative therapy for chronic pain. The ResearchKit study looks to see how wearables (in this case, the Apple Watch) can alleviate pain without relying on pharmaceutical painkillers, a commendable goal for a company whose painkilling opioid OxyContin...
By  Jonah Comstock 02:07 pm September 11, 2017
One day before another big announcement day for Apple, CEO Tim Cook has given some expansive comments to Fortune about the company's aspirations and motivations in the health space. In comments that touched on everything from the Apple Watch to ResearchKit, the tech giant CEO talked about how Apple approaches health differently than a lot of other companies. "We’re extremely interested in this...
By  Heather Mack 03:47 pm July 11, 2017
With all the recent technological approaches to clinical trials as of late, it’s clear that the notoriously long, expensive and often inefficient traditional process could use an update. From AI-powered matching platforms to increasingly sophisticated software to streamline data collection during trials, the space is getting busier. Palo Alto-based monARC Bionetworks is one of the latest to make...
By  Heather Mack 04:21 pm June 8, 2017
A little more than two years after the debut of ResearchKit, Apple has released a fresh iteration to drive the momentum and sophistication of app-based research projects. This comes on the heels of the company’s annual WWDC, during which Apple announced new health features to the Apple Watch. Along with audiovisual enhancements and improved user interface for both developers and study...
By  Jonah Comstock 04:53 pm May 16, 2017
More on Google DeepMind’s patient data misconduct. Google DeepMind’s partnership with the NHS is back in the news again as some new information emerged in the form of a leaked letter from National Data Guardian Dame Fiona Caldicott to the director of the Royal Free Hospital, where DeepMind’s apps were tested. The letter, published by Sky News, gives a glimpse into the UK government’s ongoing...
By  Heather Mack 06:18 pm March 29, 2017
Many pharmaceutical companies are now turning to digital tools to improve medication adherence, augment clinical trials, or develop parallel therapies with digital health companies. Rare is the pharmaceutical company that wants to actively get people to stop taking their medication, but that’s exactly the aim of a new study launched by Purdue Pharmaceuticals, maker of the blockbuster and...